Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +37.55%
#3 Glidr Glidr +35.94%
#4 Walrus Walrus +21.69%
#5 Tutorial Tutorial +17.00%
#6 Codatta Codatta +16.74%
#7 Humanity Humanity +15.70%
#8 Ribbita by Virtuals Ribbita by Virtuals +15.04%
#9 Enso Enso +14.38%
#10 Versatize Coin Versatize Coin +12.50%
Coin of the day
EXOD EXOD
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
Rang în acțiuni #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
Preț acțiune
$0.07600875
Ultima sincronizare: 2024-11-20
Capitalizare de piață
$2.06M
Schimbare (1 zi)
-0.51%
Schimbare (1 an)
0.00%
Țară
FR
Tranzacționează Quantum Genomics S.A. (ALQGC)

Categorie

Healthcare
Raport P/S pentru Quantum Genomics S.A. (ALQGC)
Raport P/S la data de August 2026 TTM: 499.95K
Conform celor mai recente rapoarte financiare și prețului acțiunilor Quantum Genomics S.A., raportul P/S actual (TTM) este 499.95K. La sfârșitul anului 2023, compania avea un P/S de 186.65.
Istoricul raportului P/S pentru Quantum Genomics S.A. din 2009 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
2026 (TTM) 499.95K -0.53%
2024 502.59K 269,175.26%
2023 186.65 11,422.08%
2022 1.62 -95.60%
2021 36.83 -32.65%
2020 54.68 39.21%
2019 39.28 -99.83%
2018 22.77K 0.00%
2017 0.00 0.00%
2016 0.00 -100.00%
2015 406.74 397.85%
2014 81.70 -94.18%
2013 1.40K 15.20%
2012 1.22K 290.81%
2011 311.74 0.00%
2010 311.74 -14.29%
2009 363.69 0.00%
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -100.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -100.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -100.00%
BE